Literature DB >> 12568716

Sequence diversity and evolution of the malaria vaccine candidate merozoite surface protein-1 (MSP-1) of Plasmodium falciparum.

Marcelo U Ferreira1, Weber L Ribeiro, Angela P Tonon, Fumihiko Kawamoto, Stephen M Rich.   

Abstract

The merozoite surface protein-1 (MSP-1) of the malaria parasite Plasmodium falciparum is a major blood-stage antigen containing highly polymorphic tripeptide repeats in the domain known as block 2 and several non-repetitive domains that are essentially dimorphic. We have analyzed sequence variation in block 2 repeats and in non-repetitive block 17, as well as other polymorphisms within the MSP-1 gene, in clinical isolates of P. falciparum. Repeat haplotypes were defined as unique combinations of repeat motifs within block 2, whereas block 17 haplotypes were defined as unique combinations of single nucleotide replacements in this domain. A new block 17 haplotype, E-TNG-L, was found in one isolate from Vietnam. MSP-1 alleles, defined as unique combinations of haplotypes in blocks 2 and 17 and other polymorphisms within the molecule, were characterized in 60 isolates from hypoendemic Brazil and 37 isolates from mesoendemic Vietnam. Extensive diversity has been created in block 2 and elsewhere in the molecule, while maintaining significant linkage disequilibrium between polymorphisms across the non-telomeric MSP-1 locus separated by a map distance of more than 4 kb, suggesting that low meiotic recombination rates occur in both parasite populations. These results indicate a role for non-homologous recombination, such as strand-slippage mispairing during mitosis and gene conversion, in creating variation in a malarial antigen under strong diversifying selection.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12568716     DOI: 10.1016/s0378-1119(02)01180-0

Source DB:  PubMed          Journal:  Gene        ISSN: 0378-1119            Impact factor:   3.688


  46 in total

1.  Extensive antigenic polymorphism within the repeat sequence of the Plasmodium falciparum merozoite surface protein 1 block 2 is incorporated in a minimal polyvalent immunogen.

Authors:  Kevin K A Tetteh; David R Cavanagh; Patrick Corran; Rosemary Musonda; Jana S McBride; David J Conway
Journal:  Infect Immun       Date:  2005-09       Impact factor: 3.441

2.  Longitudinal studies of Plasmodium falciparum malaria in pregnant women living in a rural Cameroonian village with high perennial transmission.

Authors:  Rose F G Leke; Jude D Bioga; James Zhou; Genevieve G Fouda; Robert J I Leke; Viviane Tchinda; Rosette Megnekou; Josephine Fogako; Grace Sama; Philomina Gwanmesia; Germaine Bomback; Charles Nama; Ababacar Diouf; Naveen Bobbili; Diane Wallace Taylor
Journal:  Am J Trop Med Hyg       Date:  2010-11       Impact factor: 2.345

Review 3.  Antigenic diversity and immune evasion by malaria parasites.

Authors:  Marcelo U Ferreira; Mônica da Silva Nunes; Gerhard Wunderlich
Journal:  Clin Diagn Lab Immunol       Date:  2004-11

Review 4.  Strain theory of malaria: the first 50 years.

Authors:  F Ellis McKenzie; David L Smith; Wendy P O'Meara; Eleanor M Riley
Journal:  Adv Parasitol       Date:  2008       Impact factor: 3.870

5.  Higher Complexity of Infection and Genetic Diversity of Plasmodium vivax Than Plasmodium falciparum Across All Malaria Transmission Zones of Papua New Guinea.

Authors:  Abebe A Fola; G L Abby Harrison; Mita Hapsari Hazairin; Céline Barnadas; Manuel W Hetzel; Jonah Iga; Peter M Siba; Ivo Mueller; Alyssa E Barry
Journal:  Am J Trop Med Hyg       Date:  2017-04-06       Impact factor: 2.345

6.  Genetic polymorphism of merozoite surface protein-1 and merozoite surface protein-2 in Plasmodium falciparum field isolates from Myanmar.

Authors:  Jung-Mi Kang; Sung-Ung Moon; Jung-Yeon Kim; Shin-Hyeong Cho; Khin Lin; Woon-Mok Sohn; Tong-Soo Kim; Byoung-Kuk Na
Journal:  Malar J       Date:  2010-05-17       Impact factor: 2.979

7.  Non-variant specific antibody responses to the C-terminal region of merozoite surface protein-1 of Plasmodium falciparum (PfMSP-1(19)) in Iranians exposed to unstable malaria transmission.

Authors:  Sedigheh Zakeri; Akram A Mehrizi; Samaneh Zoghi; Navid D Djadid
Journal:  Malar J       Date:  2010-09-16       Impact factor: 2.979

8.  Contrasting population structures of the genes encoding ten leading vaccine-candidate antigens of the human malaria parasite, Plasmodium falciparum.

Authors:  Alyssa E Barry; Lee Schultz; Caroline O Buckee; John C Reeder
Journal:  PLoS One       Date:  2009-12-30       Impact factor: 3.240

9.  The Plasmodium falciparum merozoite surface protein-1 19 KD antibody response in the Peruvian Amazon predominantly targets the non-allele specific, shared sites of this antigen.

Authors:  Patrick L Sutton; Eva H Clark; Claudia Silva; OraLee H Branch
Journal:  Malar J       Date:  2010-01-04       Impact factor: 2.979

10.  Population diversity and antibody selective pressure to Plasmodium falciparum MSP1 block2 locus in an African malaria-endemic setting.

Authors:  Nitchakarn Noranate; Franck Prugnolle; Hélène Jouin; Adama Tall; Laurence Marrama; Cheikh Sokhna; Marie-Thérèse Ekala; Micheline Guillotte; Emmanuel Bischoff; Christiane Bouchier; Jintana Patarapotikul; Jun Ohashi; Jean-François Trape; Christophe Rogier; Odile Mercereau-Puijalon
Journal:  BMC Microbiol       Date:  2009-10-15       Impact factor: 3.605

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.